HIGHLIGHTS
- who: Gian Maria Zaccaria and collaborators from the Unit of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, PoliToBIOMedLab of Politecnico Torino, Turin, Italy have published the research: A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial, in the Journal: Cancers 2022, 188 of 29/Oct/2021
- what: Even when currently limited to baseline predictors the approach has high scalability potential. The authors applied a hierarchical clustering algorithm to a large number of clinical variables from the DW, collected at baseline. The study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.